Skip to content
Precision for Medicine
Press Release

FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients

false
Jennifer, Wetmore Avatar

Jennifer Wetmore

Jennifer Wetmore is a Project Director at Precision for Medicine with 19 years of clinical research experience leading global studies across oncology, gene editing and rare disease. She specializes in partnering with emerging biotechnology companies on complex early-phase development programs, including first-in-human genome editing and solid tumor oncology trials. Over the past four years, Jennifer has overseen multiple high-profile global Phase I studies, navigating aggressive timelines, sponsor-driven changes, audits, team transitions, and complex regulatory, operational, and laboratory activities across North America, Europe, and APAC. Jennifer holds a B.A. in Biology from the University of Virginia and an M.S. in Science Education from Old Dominion University.
Loading...
You've reach the end